content

Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC

Novartis announced that the US FDA accepted the Company's supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use...

Johnson Matthey and Rennovia announce licence agreement with ADM for glucaric acid production technology

Johnson Matthey, a global specialty chemicals company and provider of advanced process technologies, and Rennovia Inc., a privately held company that develops novel catalysts...

Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products

Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary Obagi Medical Products, a long-time leader in professional skin care announced a collaboration with Nextcell Medical Company...

Videojet introduces new pink UV fluorescent ink to drive productivity

Fluorescing UV inks offer a number of advantages, including high print quality, improved durability and enhanced productivity. Fluorescing UV ink is...

eRegulatory Summit – Expert Speaker Post

Join the experts at this year's eRegulatory Summit for all the latest industry updates, regulatory advice, practical guidance & ample case studies for benchmarking...

ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials

ICON plc a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has...

Recipharm completes strategic acquisition in India

Recipharm AB announces that it has now concluded the acquisition of Kemwell’s pharmaceutical businesses located in Bengaluru, India. Highlights Expands...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read